Fig. 1From: Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysisStudy flow diagram. Records were identified through database searches and grey literature. A total of 94 articles met the criteria for full-text review, and 8 of them were finally included in the meta-analysisBack to article page